THU0441 Effect of Concomitant Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) on The Efficacy and Safety of Ixekizumab in Biologic Dmard-Naive Patients with Active Psoriatic Arthritis
THU0441 Effect of Concomitant Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) on The Efficacy and Safety of Ixekizumab in Biologic Dmard-Naive Patients with Active Psoriatic Arthritis